1. amores51049
2. WillSchibler79
3. TTrade333
4. agngolf
5. rainnwolff
1.WillSchibler79 03/26/2018
Presented data from TOPACIO trial of niraparib in combination with anti-PD-1 monoclonal antibody, KEYTRUDA; …
2.WillSchibler79 02/26/2018
Enters into clinical collaboration with Roche's Genentech
3.amores51049 01/13/2018
Relevant News: - TESARO Announces Updates to the U.S. Prescribing Information for VARUBI® (rolapitant) Injectable Emulsion
4.wasserleiche 05/04/2018
TESARO Announces First-Quarter 2018 Operating Results
5.amores51049 04/16/2018
TESARO Summarizes TSR-042 Clinical Data Presented at AACR
6.WillSchibler79 10/25/2017
Big news, FDA Approval
7.amores51049 03/27/2018
Data From TOPACIO Trial Reported at SGO Demonstrates Compelling Clinical Activity of ZEJULA in Combination With an Anti-PD-1 Antibody in Patients With Platinum Resistant/Refractory Ovarian Cancer
8.agngolf 02/27/2018
TESARO Announces Collaboration to Evaluate Combination of ZEJULA® (Niraparib) and Anti-PD-L1 Cancer Immunotherapy in Metastatic Bladder Cancer
9.TTrade333 10/26/2017
The next big catalyst will be Nov 7. Investor presentation + Earning Conference call on the same day
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW